Welcome: Guest | Site Use Options | Register | Login |

21st Century Therapeutics Inc

Profile last edited on: 2/18/19
440 Burroughs Street Suite 447
Detroit, MI 48202
  (248) 545-0595
Business Identifier: Anti-tumor compounds
Public Profile:
21st Century Therapeutics is a product-focused, development-oriented biotech company that very soon after being founded placed six anti-tumor compounds into human clinical studies through licensing to pharmaceutical companies. The firm's exclusive ORION discovery and development platform combines a unique and novel in vitro Solid Tumor Selective (STS) technology with an exclusive Chemistry, Clonogenic, Formulation and Pharmacology studies (CCFP) platform to ensure that its drugs will be bioavailable and active in subsequent in vivo Therapeutic Assessment. Data from all these components, together with a Molecular Brushing (MB) platform, are blended in a proprietary manner to identify and characterize potential clinical strengths and weaknesses of an experimental anti-cancer drug. The added value of this approach includes early stage prediction of the drugs therapeutic effectiveness in humans as well as the novel target mechanism by which it acts

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920